Anti-VEGF injection frequency correlates with visual acuity outcomes in pro re nata neovascular AMD treatment

Clinical trials report substantial gains in visual acuity (VA) for eyes treated with intravitreal anti-VEGF for neovascular AMD (nAMD). In clinical reality, VA outcomes are more variable. Here we investigate pro-re nata treatment frequencies and VA in a real-life cohort of 1382 eyes (1048 patients)....

Descripción completa

Detalles Bibliográficos
Autores principales: Wecker, Thomas, Grundel, Bastian, Reichl, Sabine, Stech, Milena, Lange, Clemens, Agostini, Hansjürgen, Böhringer, Daniel, Stahl, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397189/
https://www.ncbi.nlm.nih.gov/pubmed/30824721
http://dx.doi.org/10.1038/s41598-019-38934-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397189/
https://www.ncbi.nlm.nih.gov/pubmed/30824721
http://dx.doi.org/10.1038/s41598-019-38934-8

Ejemplares similares